SummaryMulti-cancer blood tests like Galleri are gaining attention for their ability to detect cancers without routine screening. Demand is rising despite high costs and limited evidence. Studies show improved performance but notable false positives and missed cases. Experts say more large trials are needed to prove these tests actually reduce cancer deaths.